SOURCE: Industrial Info Resources

Industrial Info Resources

March 29, 2016 07:30 ET

Almost the Same, but Not Quite... Biosimilars Market Expected to Hit $25 Billion by 2020, an Industrial Info News Alert

SUGARLAND, TX--(Marketwired - Mar 29, 2016) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Generics have long been the bane of Big Pharma. Waiting in the wings until a drug's patent expires, low-cost copycats then flood into the market as pharma companies watch their profits take a dive. The market was once limited to traditional pharmaceutical products, but this is no longer true as a growing number of biopharmaceuticals, or biologics, are headed for their own patent cliff.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

    Brian Ford
    (713) 980-9393